Popular Searches
Useful Links
Value Chain Analysis Case Study
Case Title:
Big Pharma R&D: Is it worth spending?
Publication Year : 2004
Authors: B N Renuka Prasad, Christoph
Industry: Health Care
Region:USA
Case Code: VCA0002
Teaching Note: Not Available
Structured Assignment: Not Available
OR
Abstract:
Big Pharma like Pfizer, Glaxo and Novartis spend as much as $30 billion a year on R&D. But the number of new molecular entities resulting from such R&D spend is shrinking.
Pedagogical Objectives:
- To highlight the decreasing number of new molecular entities
- To discuss the other challenges faced by today's Big Pharma.
Keywords : Big pharma; R&D; Pfizer; Novartis; New molecular entities; Eli Lilly; Astrazeneca; Bristol-Myers Squibb; Sanofi-Synthelabo; Industry Analysis Case Study; Schering-Plough; Merck; Pharmaceutical; GlaxoSmithKline; USFDA; Drugs
Contents:
- Introduction
- Challenges
- Conclusion
Related Case Studies
- » Wegmans: The US Retailer’s Success Formula
- » Novartis: Globalization of Pharmaceutical Research
- » Novartis' Generic Drug Business: The New Growth Driver
- » The Indian Pharmaceutical Industry: Opportunities and Challenges
- » ‘Clinical Trials’: Outsourcing to India
- View all Value Chain Analysis case studies »
Recently Bought Case Studies
Global Banking Industry: The New Horizons
Price: $25
Hardcover edition
ISBN 978-81-314-2414-8
Fast Food Retailing Industry - Vol. I
Price: $25
Hardcover edition
ISBN 978-81-314-2456-8
Decision Making
Price: $50
Hardcover edition
ISBN 978-81-314-1571-9- View all Casebooks »
Case Studies On
Course Case Mapping For Financial Management - I
Price: $Course Case Mapping For Financial Management - I
Hardcover edition
Course Case Mapping For Quantitative Methods
Price: $Course Case Mapping For Quantitative Methods
Hardcover edition
Course Case Mapping For Marketing Management - I
Price: $Course Case Mapping For Marketing Management - I
Hardcover edition- View All Course Casemaps»
Course Case Mapping For
An Interview with Personnel of Vaatsalya Group
Price: $Vaatsalya Hospitals (B): The Operational Model
An interview with Dr. Ashwin Naik & Dr. Veerendra Hiremath
Price: $Vaatsalya Hospitals (A): The Business Model
An Interview with Dr.Rajiv Malhotra & (Prof)Dr.M.P.Sharma
Price: $Managing a World-Class Hospital: The Rockland Story- View all Video Interviews»
Video Interviews
Training and Development
Executive Brief with Anjali Mukherjee
Highly Recommended for Human Resource Management / Training and Development Course
You Can't Play by Rules, Always
Executive Brief with R.D. Prasad, Product Manager.
Highly Recommended for Organizational Behavior Course
New Recruit MBAs Attitudes
Executive Brief with Lopamudra Ray, Keya Gupta and Deepika Lingala.
Highly Recommended for Organizational Behavior Course- View all Executive Briefs»
Executive Brief
David Conklin
David Conklin, is a professor at the Richard Ivey School of Business
Speaks on Government and Business
Lord Meghnad Desai
Lord Meghnad Desai, is an Indian-born British economist and Labor politician
Speaks on Government and Business
Vijay Govindarajan
Vijay Govindarajan, is widely regarded as one of the world’s leading experts on strategy and innovation
Speaks on Reverse Innovation- View All Executive Interviews»
